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ABSTRACT 
 
Autism spectrum disorder (ASD) is characterized by difficulties in social interaction, 
communication and language, and restricted repertoire of activities and interests. 
The etiology of ASD remains unknown and no clinical markers for diagnosis were 
identified. Environmental factors, including prenatal exposure to valproic acid (VPA), 
may contribute to increased risk of developing ASD. MicroRNA (miRNA) are small 
noncoding RNA that regulate gene expression and are frequently linked to biological 
processes affected in neurodevelopmental disorders. In this work, we analyzed the 
effects of resveratrol (an antioxidant and anti-inflammatory molecule) on behavioral 
alterations of the VPA model of autism, as well as the levels of circulating miRNA. 
We also evaluated the same set of miRNA in autistic patients. Rats of the VPA model 
of autism showed reduced total reciprocal social interaction, prevented by prenatal 
treatment with resveratrol (RSV). The levels of miR134-5p and miR138-5p increased 
in autistic patients. Interestingly, miR134-5p is also upregulated in animals of the 
VPA model, which is prevented by RSV. In conclusion, our findings revealed 
important preventive actions of RSV in the VPA model, ranging from behavior to 
molecular alterations. Further evaluation of preventive mechanisms of RSV can shed 
light in important biomarkers and etiological triggers of ASD. 
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 1. Introduction 
Autism spectrum disorder (ASD) is a neurodevelopmental disorder of unknown 
etiology characterized by a dyad of behavioral alterations: a) social communication 
and social interaction impairments and b) restricted, repetitive and stereotyped 
patterns of behavior, interests and activities (American Psychiatric Association, 
2013). In addition to these features, several other associated symptoms and 
comorbidities are more prevalent in individuals with ASD, including sensorial, 
gastrointestinal, and immune alterations, sleep disturbances and other neurological 
disorders such as epilepsy and TDAH (Geschwind, 2009; Grandin, 2009; Klintwall et 
al., 2011).  
The development of complex neural circuits relies in the spatial and temporal 
coordination of genetic and epigenetic processes during embryogenesis. As a 
consequence, the neurodevelopment is especially susceptible  to the influence of 
environmental factors (Ameis and Catani, 2015; Perera and Herbstman, 2011).  The 
brain of autistic individuals present several structural and functional abnormalities  
(Hutsler and Casanova, 2016), which could be caused by environmental risk factors, 
including immune abnormalities during pregnancy, indicating a strong influence of 
the immune system in the neurodevelopment. (Gottfried et al., 2015).  
Valproic acid (VPA) is a drug widely-used as anticonvulsant and mood-
stabilizer. Epidemiological observations demonstrated a strong link between the 
prenatal exposure to VPA, and the onset of ASD in the offspring (Christianson et al., 
1994; Moore et al., 2000; Rodier et al., 1997; Williams et al., 2001; Williams and 
Hersh, 1997). Based on these observations, a prenatal injection of VPA  has been 
used to induce autistic-like features in animal models in rodents (Bambini-Junior et 
al., 2011; Schneider and Przewłocki, 2005). The VPA animal model of autism 
presents face validity (strong phenomenological similarities and related 
pathophysiology), construct validity (the same etiology; in this case, exposure to 
VPA) and predictive validity (same response to treatments aiming to prevent or revert 
symptoms) (Mabunga et al., 2015). Therefore, this model is currently  used to 
elucidate new pathways involved in ASD pathophysiology that can be 
pharmacologically targeted (Tyzio et al., 2014).  
Given the importance of social behavior impairments for the diagnosis of ASD, 
analysis of social behavior is critical in models of autism in rodents. We previously 
demonstrated that rats of the VPA model present impaired social behavior in  a 
three-chambered social approach task (Bambini-Junior et al., 2011). In addition, we 
showed that resveratrol (RSV), an antioxidant and anti-inflammatory molecule, 
prevents social impairments in the VPA model in this same test (Bambini-Junior et 
al., 2014). Another key component for ASD diagnosis is the presence of repetitive 
and stereotyped behaviors, which, in animal models, are commonly manifested by 
excessive and incomplete self-grooming (McFarlane et al., 2008; Schneider and 
Koch, 2005; Sungur et al., 2014).  Animal models of autism also frequently present 
irregularities in sensorial processing (Dendrinos et al., 2011; Geschwind, 2009), 
which may interfere with  the animals’ ability to perceive and interact with their 
surroundings  (Nienborg and Cumming, 2010). The social transmission of food 
preference (STFP) is an ethologically relevant test of hippocampus-dependent non-
spatial olfactory memory (Galef-Jr and Wigmore, 1983) that is commonly used to 
evaluate social communication in rodents (Bessières et al., 2017; Ryan et al., 2008).  
Therefore, in this work we evaluated reciprocal social interaction, repetitive self-
grooming and the STFP task in rats of the VPA model, as well as the influence of 
prenatal RSV treatment.  
In addition to behavioral assessments, the investigation of common molecular 
targets of VPA and RSV could help to clarify pathways involved in the 
pathophysiology of ASD. MicroRNA (miRNA) are a set of small non-coding RNA that 
control protein expression by binding mainly to the 3’UTR of the messenger RNA 
(mRNA) and thereby mediating either RNA degradation or translation inhibition 
(Chandra et al., 2017). The miRNA molecules are able to modulate several cellular 
functions and events, including cellular proliferation and differentiation, synapse 
formation/maturation and general metabolism integration (Wahid et al., 2010) and 
were recently implicated in the pathogenesis of ASD (Wu et al., 2016). The 
identification of circulating miRNA may also be potentially relevant for the 
development of clinical diagnostic or prognostic tools (Hu et al., 2017). We 
hypothesized that the RSV’s preventive effect of the VPA-induced impairments might 
involve modulation of miRNA levels. In addition, we anticipate that some of these 
results could be conserved inter-species and would also be relevant for patients with 
ASD. 
Thus, the aims of the present study were to investigate possible preventive 
effects of RSV against VPA-induced impairments on behavior and circulating miRNA 
alterations in an animal model, as well as to evaluate miRNA alterations in blood 
from autistic patients.   
2. Material and Methods 
2.1. Animal model of autism induced by VPA and resveratrol treatment 
The animal model of autism was induced as previously described (Bambini-
Junior et al., 2011; Schneider and Przewłocki, 2005). Briefly, female Wistar rats 
(UFRGS-Biochemistry Department CREAL), with controlled fertility cycles, were 
mated overnight. The first day of gestation was determined by the presence of 
spermatozoa in the vaginal smear (embryonic day 0.5). Pregnant females received a 
single intraperitoneal injection of 600 mg/kg VPA (sodium valproate, Sigma-Aldrich, 
USA) or saline solution on embryonic day 12.5 (E12.5), and daily subcutaneous 
injections of RSV (3.6 mg/kg) or DMSO from E6.5 to E18.5 (Bambini-Junior et al., 
2014). Only males of the offspring were used in this current study. Blood samples 
from these animals were obtained by cardiac puncture 30 days after birth. The 
behavioral analyses were performed in a second cohort of animals. This project was 
approved by the local animal ethics committee (CEUA-UFRGS 140367/140431) and 
all animals were handled in accordance with the current guidelines (National Council 
for the Control of Animal Experimentation - CONCEA). 
2.2. Behavioral tests 
To investigate possible preventive effect of RSV treatment on VPA animals, we 
evaluated three important behavioral patterns that correspond to behavioral domains 
frequently altered in ASD: sociability, olfactory memory and communication, and 
repetitive behavior. 
2.2.1. Reciprocal social behavior 
The test was adapted from Schneider and Przewlocki (Schneider and 
Przewłocki, 2005). Rats were tested at 46 days of age in a 50x50x50 cm arena. After 
a 5-min habituation period in the test chamber, the interactions between the animal 
test and a novel rat (younger male) were recorded for 15 min. The following pro-
social interactions were evaluated: nose-to-nose sniffing, anogenital inspection, 
flank-exploration and following behavior. The number and duration of events were 
scored using the Anymaze software. We also calculated the total   number and time 
of reciprocal social interaction. 
2.2.2. Social transmission of food preference (STFP) 
The experiment was adapted from Wrenn et al protocol (Wrenn et al., 2004). 
Rats at 47 days of age were habituated for 72 hours to eat pelleted food made from 
powdered chow. In the following day, food was removed three hours before the test. 
Next, one animal from each cage (demonstrator) was housed alone in a separate 
housing box and could eat a randomly assigned flavored food for 1 hour: either 
cinnamon (1% w/w) or cocoa (2% w/w). Then the demonstrator rat was housed with 
their littermates (the observer rats) and allowed free interaction for 30 min. After this 
interaction period, the demonstrator animal was removed from the housing box and 
the observer animals were provided with two choices of powdered food in identical 
pellets, one with flavor of the cued food presented by demonstrator rat and the other 
with the alternative food. Rats could eat for one and a half hours, and the amount of 
cued and non-cued food eaten from each litter was weighed and recorded. The ratio 
of food preference for each litter was calculated, considering the amount of cued and 
non-cued food and the total food consumption. 
2.2.3. Repetitive self-grooming behavior 
Rats at 64 days of age were scored for spontaneous grooming behavior as 
described (Onaolapo et al., 2017). The test was performed during 10 min in a 
50x50x50 cm arena. Each rat was scored individually in two parts (0-5 min and 5-10 
min) and the total time (0-10 min), considering the number of body cleaning with 
paws and face-washing actions. No habituation was performed. 
2.3. Blood samples from autistic and control subjects 
Peripheral blood samples from autistic male individuals and from the control 
group (5-15 years-old range) were obtained at the Clinical Hospital of Porto Alegre 
(HCPA).  Inclusion criteria were age between 5 and 15 years and clinical diagnosis of 
ASD according to DSM-5 confirmed using the Autism Diagnostic Observation 
Schedule. Autistic individuals who presented secondary autism or autism as an 
associated feature of an identified genetic condition (Fragile X Syndrome, Rett 
Syndrome, Angelman Syndrome, Prader-Willi Syndrome, Smith-Lemli-Opitz 
Syndrome and Tuberous Sclerosis) were excluded from the study. This project was 
approved by the local ethics committee (CEUA-UFRGS 33863). 
2.4. RNA Extraction and RT-qPCR Procedure 
After homogenization of blood samples with Trizol® reagent (Invitrogen, 
USA), chloroform was added to perform phase separation, and RNA was 
precipitated from the upper aqueous layer using isopropanol. The 
precipitated RNA was washed with ethanol to remove impurities, 
resuspended in RNase-free water and stored at -80ºC (Chomczynski, 1993). 
Mature miRNA expression was evaluated by reverse transcriptase followed 
by quantitative polymerase chain reaction (RT-qPCR) (Chen et al., 2005). 
Complementary DNA (cDNA) was synthesized from mature miRNA using 
reverse transcriptase reaction containing 2 μg of total RNA, 1 μL of 10 mM 
dNTP mix (Invitrogen, USA), 3 μL of stem loop RT primer mix (Data in Brief 
Table 1), 4 μL M-MLV reverse transcriptase 5X reaction buffer (Invitrogen, 
USA), 2 μL of 0.1 M DTT (Invitrogen, USA), 1 μL of RNase inhibitor 
(Invitrogen, USA), 1.0 μL of M-MLV reverse transcriptase (Invitrogen, USA), 
and sterile distilled water to a final volume of 20 μL. The synthesis of the 
cDNA was completed after a sequence of three incubations at 65ºC for 5 
min, 37ºC for 50 min and 70ºC for 15 min.  
The quantitative PCR mix was comprised by 12 μL of cDNA (1:33), 1.0 
μL of specific miRNA forward and universal reverse (10 μM) primers (as 
detailed in Data in Brief Table 1), 0.5 μL of 10 μM dNTP mix, 2.4 μL of 10X 
PCR buffer (Invitrogen, USA), 0.8 μL of 50 mM MgCl2 (Invitrogen, USA), 2.4 
μL of 1X SYBRTM Green (Molecular Probes, USA), 0.1 μL of Platinum Taq 
DNA Polymerase (Invitrogen, USA) and sterile distilled water to a final 
volume of 24 μL. The fluorescence of SYBRTM Green was used to detect 
amplification, estimate Ct values, and to determine specificity after melting 
curve analysis. PCR cycling conditions were standardized to 95ºC for 5 min 
followed by 40 cycles at 95ºC for 10 s, 60ºC for 10 s, and 72ºC for 10 s. After 
the main amplification, sample fluorescence was measured from 60ºC to 
95ºC, with an increasing ramp of 0.3ºC each, to obtain the denaturing curve 
of the amplified products and Tm estimation, to assure their homogeneity 
after peak detection. Data was obtained from an Applied Biosystems 
StepOne System (USA). The set of 16 miRNA selected for this study 
includes miRNA involved in immunological and/or synaptic plasticity 
modulation, processes altered in ASD and includes miRNA commonly 
altered in many neurodevelopmental disorders.  
2.5. Calculation of miRNA relative expression  
The RT-qPCR results were imported into Microsoft Excel and the 
geNorm program was used to assess the variance in expression levels of the 
miRNA analyzed (Peltier and Latham, 2008; Vandesompele et al., 2002). 
This program scanned the present miRNA two at a time. Then, the 
expression stabilities of the set of miRNA were evaluated and ranked 
accordingly to their stability. A pairwise variation analysis was performed by 
geNorm to determine the number of miRNA required for accurate 
normalization and to identify the most suitable miRNA to be used as 
normalizers. 
The average value of crossing threshold (Ct) values (in triplicate) was 
converted to quantities for geNorm analysis by the difference between Ct 
value from two groups taken in each comparison.  PCR efficiency was 
calculated from the slope of the amplification curve by exponential 
amplification analysis using the LinRegPCR algorithm (Ramakers et al., 
2003). The relative expression was obtained using the -ΔΔCt method where 
Ct values of a group are subtracted from the average Ct values of the control 
group. The relative expression of miRNA was calculated considering the 
PCR efficiency and the –ΔΔCt values for each miRNA (Pfaffl, 2001) and was 
normalized to the normalizers identified by the geNorm software.  
2.6. Statistical analysis 
IBM SPSS Statistics 20.0 (IBM SPSS, Armonk, NY, USA) was used to perform 
the statistical analysis. Kolgomorov-Smirnov and Shapiro-Wilk tests of normality 
were applied to determine data distribution. For reciprocal sociability test and self-
grooming behavior, we used Generalized Estimating Equations (GEE) to weight both 
the interventions (VPA exposure and/or RSV treatment) and the litter effect in the 
behavioral outcome. After a Wald Chi-Square test, we performed pairwise 
comparisons for the parameters that presented interaction effect between 
interventions (VPA-by-RSV interaction). If only main effects were observed, the 
individual effect of VPA or RSV was evaluated. Bonferroni’s post hoc test was used 
as the final evaluation. Data is reported as mean ± standard error of the mean 
(SEM). The Poisson distribution was used for discrete variables (number of 
interactions), while gamma distribution was used for time variables. A two-way 
variance analysis and Bonferroni post hoc test were used to analyze the cued 
food/total food eaten percentage during the STFP test after normality tests indicated 
a normal distribution of this variable. The associated data are expressed as mean ± 
SEM and P<0.05 was considered to indicate a statistically significant difference. On 
the other hand, the absolute consumption of each food flavor presented non-normal 
distribution, were compared by non-parametric Kruskal–Wallis test and the results 
were expressed as median ± interquartile interval.  
The miRNA relative expressions of the four animal groups were compared 
using non-parametric Kruskal–Wallis test followed by Dunn’s test for multiple 
comparisons. The results were expressed as median ± interquartile interval. For the 
analysis of the human samples, non-parametric Mann-Whitney U test was performed 
and the results were expressed as median± interquartile interval. All statistical 
analyses were supervised by the Biostatistics Unit at the Clinical Hospital of Porto 
Alegre. 
3. Results 
3.1. Behavioral tests  
3.1.1. Reciprocal Sociability Test 
Adult male rats prenatally exposed to VPA were tested in a sociability paradigm 
considering four pro-social behaviors: nose-to-nose sniffing, anogenital inspection, 
flank exploration and following (Figure 1). Wald chi-square test showed a significant 
interaction effect between VPA exposure and prenatal RSV treatment in all 
parameters evaluated. Bonferroni’s test for multiple comparisons further revealed 
that animals from the VPA group presented significantly decreased number and time 
of nose-to-nose sniffing compared to the control group, and RSV was not able to 
completely prevent these alterations (Fig 1A). Anogenital inspection presented no 
significant difference between experimental groups (Fig 1B). There was no difference 
between number and time of flank exploration behavior between VPA and control 
groups, although a significant difference in total time of this behavior was observed 
between VPA and RSV groups (Fig 1C). Rats prenatally exposed to VPA also 
displayed significantly reduced number and time of following behavior when 
interacting reciprocally with an unfamiliar rat, compared to the control group (Fig 1D). 
Animals exposed to VPA presented decreased total pro-social interactions and spent 
less time interacting with an unfamiliar conspecific rat compared to the control group 
(Fig 1E). When VPA animals are treated with RSV, there was a significant increase 
in both number and time of pro social behaviors compared to VPA animals injected 
only with the vehicle. Thus, the RSV treatment was able to prevent the combined 
social deficits of VPA rats, even though analyses of individual behaviors were not 
statistically significant.    
3.1.2. Social transmission of food preference 
Figure 2 represents the ratio of food preference of Wistar rats prenatally 
exposed to VPA, compared to the control animals, after treatment with RSV or 
vehicle. There was a significant effect of VPA exposure in food preference (p=0.026), 
with a decreased ratio of food preference. However, the RSV treatment was not able 
to prevent this alteration.  
Regarding the absolute food consumption, animals exposed to VPA tend to eat 
less food with the flavor cued by the demonstrator (Data in Brief Figure 1A, p=0.080). 
On the other hand, animals presented no differences in consumption of alternative 
(non-cued) food across interventions (Data in Brief Figure 1B, p=0.493). 
3.1.3. Repetitive self-grooming 
The self-grooming behavior was evaluated across two testing periods (0-5 and 
5-10 minutes). During the first period, no significant effect was found, indicating that 
the time spent self-grooming was the same for all animals tested (Fig 3B).  In the 
second period of test, Wald chi-square test showed that animals exposed to VPA 
spent more time self-grooming and this effect was not prevented by RSV (Figure 3B, 
p=0.005).  A similar result was observed in relation to total test period, with animals 
exposed to VPA spending more time grooming and no preventive effect of RSV 
(Figure 3C, p=0.008). The latency to start a self-grooming behavior was similar 
across experimental groups (Figure 3D). 
3.2. Analysis of miRNA expression in animal model of autism 
We determined the relative expression of miRNA in blood of 30 days-old rats 
prenatally exposed to VPA or vehicle (saline) and treated with RSV or vehicle 
(DMSO). The GeNorm algorithm ranked miRNA miR181a-5p and miR181b-5p as 
most stable and they were used as normalizers to evaluate the relative expression of 
the remaining miRNA. miR134-5p was significantly increased (p=0.030) in total blood 
of animals prenatally exposed to VPA, and RSV was able to prevent this alteration 
(Figure 4). On the other hand, there were no significant differences in the 13-
remaining miRNA (Data in Brief Figure 2).  
3.3. Analysis of miRNA expression in autistic subjects 
We also determined the relative expression of miRNA in peripheral blood of 
autistic subjects, comparing with controls in the same age-range (5-15 years). The 
GeNorm algorithm ranked miR23a-3p, miR146a-5p and miR181a-5p as most stable 
and they were used as normalizers to evaluate the relative expression of the 
remaining miRNA. There were no intra-group differences related to age on miRNA 
levels. The analysis of relative expression revealed significant increases in 
expression of miR134-5p (Figure 5A, p=0.011) and miR138-5p (Figure 5B, p=0.026) 
in peripheral blood of autistic children, compared to control subjects. Levels of the 
11-remaining miRNA showed no differences between groups (Data in Brief Figure 3).  
4. Discussion 
The prenatal exposure to VPA has been used to mimic the ASD pathogenesis 
in animals for two decades, providing important insights about the morphological, 
biochemical and behavioral characteristics of ASD (Bambini-Junior et al., 2011; 
Rodier et al., 1997; Schneider et al., 2008; Schneider and Przewłocki, 2005). 
Nevertheless, the exact mechanisms by which VPA acts are still currently unknown. 
Social behavior impairments are a key defining feature of ASD (Dover and Le 
Couteur, 2007; Pascoe, 2014; Rapin and Tuchman, 2008) and are also seen in many 
animal models of autism, including the VPA animal model (Bambini-Junior et al., 
2011; Schneider et al., 2008; Schneider and Przewłocki, 2005). However, the 
mechanisms that underlie these impairments are also poorly understood. Our group 
previously demonstrated that prenatal administration of RSV (daily subcutaneous 
injections from E6.5 to E18.5) prevented ASD-like social deficits induced by VPA in 
rats (Bambini-Junior et al., 2014). Thus, the investigation of common targets of VPA 
and RSV in rodents can potentially facilitate the elucidation of the mechanisms by 
which VPA triggers the ASD-like social impairments. Moreover, it might contribute to 
the discovery of new clinical markers and the development of novel therapeutic 
approaches for ASD.  
In the present study, we extended these analyses to include other behavioral 
assessments: reciprocal social behavior, social transmission of food preference and 
repetitive self-grooming. Here, we confirm the preventive actions of prenatal 
exposure of RSV on social impairments of the VPA model of autism. VPA rats 
showed reduced total reciprocal social interaction with a conspecific (anogenital 
inspection, flank exploration, nose-to-nose sniffing and following behavior), which 
was prevented by the RSV intervention. 
Whereas the reciprocal social interaction test primarily focuses on social 
behavior of a test animal  with an unfamiliar conspecific (Schneider and Przewłocki, 
2005), the STFP test allows investigating of social communication by analyzing the 
transmission of  preferences for specific foods between conspecifics (Bessières et 
al., 2017). Surprisingly, RSV was not able to prevent the effects of VPA in the STFP 
test. Perhaps, VPA rats might have an impaired ability to detect, process or utilize 
socially transmitted information. Moreover, the fact that RSV is not able to prevent 
the deficits triggered by VPA in the SFTP, while being effective in social impairments, 
suggests that neural processes independent of social interaction might be important 
for a normal STFP behavior.   
Rats exposed to VPA also spent more time self-grooming than the controls, 
especially in the second half of this 10-minutes test protocol, which was not 
prevented by RSV. Hence, RSV can prevent some but not all aspects altered by 
VPA. The apparent specificity of RSV for social behaviors deserves further 
investigation and can be used to narrow analysis down to pathways underlying the 
development of social impairments in ASD.  
In addition to these behavioral findings, we identified miR134-5p as a miRNA 
altered in opposing ways by VPA and RSV. Interestingly, this same miRNA was also 
elevated in autistic patients compared to controls and we also identified a similar 
elevation on the circulating levels of miR138-5p in autistic patients. Intriguingly, both 
miR134-5p (Schratt et al., 2006) and miR 138-5p (Obernosterer et al., 2006) are 
thought to be brain-specific. miR134-5p is localized at the synapto-dendritic 
compartment of rat neurons and is able to negatively regulate the size of dendritic 
spines in postsynaptic sites by inhibiting the translation of an mRNA encoding the 
protein kinase Limk1, which controls spine development (Schratt et al., 2006). On 
the other hand, miR138-5p may also be implicated in changes in the development 
of dendritic spines, since it favors the activation of the RhoA-Rock pathway (Figure 
6) (Schratt, 2009; Siegel et al., 2009).Therefore, investigation of this model, 
especially of the molecular mechanism of VPA action, can shed light in important 
biomarkers and etiological triggers of ASD. 
Overall, our study suggests that evaluation of miRNA expression profile may be 
used to identify biological pathways altered in ASD. Since miRNA can pass to 
bloodstream from cells, tissues and organs (Creemers et al., 2012; Ludwig et al., 
2016), changes in circulating miRNA levels may reflect changes in other tissues, 
including nervous system and lymphoid organs. Further studies are necessary to 
evaluate additional miRNA and assess different developmental stages and tissues to 
clarify the roles of miRNA in the etiology of ASD. Nevertheless, the translational 
approach employed in this work could further support the potential use of miRNA as 
biomarkers and therapeutic targets in ASD. 
Future studies exploring the molecular alterations induced by VPA during 
pregnancy, and how this changes lead to long-term effects in the offspring are 
necessary. This is particularly important because epigenetic modulation may mediate 
the onset of ASD phenotypes (Andrews et al., 2017; Gottfried et al., 2015; Perera 
and Herbstman, 2011). In addition, studies of VPA effects on mother to embryo 
communication can help to clarify mechanisms involved in the etiology of ASD. The 
anti-inflammatory and antioxidant properties of RSV might be protective for this 
mother-embryo relationship in animals of the VPA model of autism. 
In summary, our findings revealed important preventive actions of RSV in the 
VPA model of autism. These effects ranged from behavior, (as seen in the evaluation 
of reciprocal social interaction), to molecular alterations (miR134-5p expression). We 
also demonstrate for the first time that animals exposed prenatally to VPA had no 
preference in consuming the food presented by the demonstrator, indicating that 
social communication could be impaired in this model. This study reinforces the 
validity of the VPA model of autism and its utility to study the ASD pathophysiology. 
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 Legends of Figures 
 
Figure 1. Resveratrol prevents deficits in reciprocal social interaction in the 
VPA model of autism. Number and time of nose-to-nose sniffing (A), anogenital 
inspection (B), flank exploration (C), following (D) and total pro-social interactions 
(E). Plots show mean ± SEM. Different letters indicate statistical differences with 
p<0.05. Statistical analysis: Generalized Estimating Equations (GEE) followed by 
Bonferroni. Control (n = 8), RSV (n = 9), VPA (n = 9), VPA+RSV (n = 6). 
 
Figure 2. VPA exposure impairs social transmission of food preference. 
Percentage of cued food consumed by observer rats. Data expressed as mean ± 
SEM with *p<0.05. Statistical analysis: Two-way ANOVA followed by Bonferroni. 
Control (n = 7), RSV (n = 6), VPA (n = 8), VPA+RSV (n = 7). 
 
Figure 3. VPA exposure increases self-grooming behavior. Time of grooming 
(sec): (A) 0-5 min of test, (B) 5-10 min of test, (C) total time and (D) latency to start 
grooming. Data expressed as mean ± SEM with *p<0.05 and **p<0.01 considered 
significant. Statistical analysis: Generalized Estimating Equations (GEE) followed by 
Bonferroni. Control (n = 14), RSV (n = 12), VPA (n = 12), VPA+RSV (n = 13). 
 
Figure 4. miR134-5p expression is increased in peripheral blood of the VPA 
model of autism, which is prevented by RSV treatment.  Plots presented as 
medians ± interquartile intervals with *p<0.05 considered significant. Statistical 
analysis: Independent-Samples Kruskal-Wallis followed by Dunn’s test. Control (n = 
6), RSV (n = 6), VPA (n = 6), VPA+RSV (n = 5). 
 Figure 5. mi134-5p and miR138-5p are upregulated in peripheral blood of 
autistic children compared to control group. Results expressed as median ± 
interquartile intervals with *p <0.05 considered significant. Statistical analysis: Mann-
Whitney U-test. Control (n = 7) and autistic patients (n = 7). 
 
Figure 6. Modulation of dendritic spines by miR134-5p and miR138-5p. The 
cytoskeleton within dendrites and spines is dynamically regulated by two antagonistic 
pathways: RhoA–ROCK cascade and a Rac–LIMK1 signaling. miR138-5p favors 
activation of the RhoA pathway and spine shrinkage by downregulation of the 
depalmitoylation enzyme APT1 and the resulting membrane localization and 
activation of the RhoA stimulatory Gα protein. On the other hand, miR134-5p inhibits 
LIMK1 production, thereby reducing the polymerization of filamentous actin and 
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